Metri Bio CEO Ashley Abel co-authors review in Nature Biomedical Engineering

Metri Bio CEO and co-founder Ashley Abel is co-first author of a new review in Nature Biomedical Engineering on endometrial modeling and endometriosis. The paper traces how endometrial models have evolved, from early 2D cell cultures to next-generation organoids and multi-lineage assembloids, and explains why these human-based systems capture physiology that animal models often miss. Ashley co-authored the review with Adriana N. Vélez Avilés and Yale professors Berna Sozen and Hugh Taylor.
Our mission

Metri Bio is working to radically improve the lives of people suffering from endometriosis and uterine diseases.